AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 82 min read$TLRY

Tilray Brands Q1 Revenue Rises 23% to $257.1 Million as Beverage Sales Surge Following BrewDog Acquisition

Tilray Brands reported a 23% revenue increase to $257.1M for Q1 2027, driven by an 82% surge in beverage sales following the BrewDog acquisition. Gross profit rose 35% to $77.5M, but adjusted EBITDA declined. Cannabis revenue fell, while debt was reduced by $42M. The company maintained its adjusted EBITDA guidance of $68M-$75M for the year.

Original reporting
finance.yahoo.com
Published Oct 8, 2026, 12:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 12:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Tilray Brands Q1 Revenue Rises 23% to $257.1 Million as Beverage Sales Surge Following BrewDog Acquisition — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$TLRYNeutralMed
01

Why it matters

Earnings release with mixed results; revenue growth offsets loss, guidance unchanged.

02

Market read

Tilray's earnings may influence cannabis sector sentiment and beverage‑related growth narratives.

03

What to watch

Debt reduction and strong cash position may provide runway for strategic acquisitions.

Relevance 8/10Novelty 7/10Timing: after-hours

Background

Tilray Brands, a US‑listed cannabis and beverage company, disclosed its first‑quarter 2027 financials following the BrewDog acquisition.

Company-level read

Ticker impact

$TLRYNeutralHigh confidence
Context

Tilray Brands reported Q1 2027 results with 23% revenue growth, an $40M net loss and reaffirmed full-year adjusted EBITDA guidance.

Expected impact

likely modest pressure as investors weigh loss versus revenue growth

Evidence & confidence

Revenue beat is positive, but a $40M loss and declining adjusted EBITDA may limit upside; guidance unchanged reduces surprise.

Market effects

Sector

Beverage segment growth may boost cannabis‑adjacent consumer‑product stocks.

Regional

North American cannabis and beverage markets see modest attention.

Global

Limited; primarily impacts Tilray and peers in the cannabis sector.

Counterpoint

What could challenge this read

The revenue boost from BrewDog could signal a longer‑term upside if margins improve.

Key entities

  • Company
    Tilray Brands, Inc.

    US‑listed cannabis and beverage producer (NASDAQ:TLRY).

  • Company
    BrewDog

    Acquired beverage brand contributing to Tilray's revenue surge.

Read at source← All news

Also covered by

2 outlets

Related articles

OCT 8
$TLRYMed

Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit…

Tilray Brands, Inc. (TLRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution First-Quarter Results

SEC EDGAR 8-K2 min
AUG 24
$CURLFHighAI 9/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf has made an unsolicited bid for Aurora Cannabis, offering a 45% premium. Aurora has not accepted the deal. Tilray Brands and Canopy Growth are also engaging in consolidation. Aurora recently acquired Safari Flower, while Canopy bought MTL Cannabis. Tilray is diversifying into alcohol and CBD. Investors should consider risks of consolidation strategies.

aol.com3 min
AUG 23
$TLRYMed

Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?

Tilray Brands reported record fiscal 2026 revenue of $915 million, up 11%, and adjusted EBITDA of $61.1 million, also up 11%. Adjusted net income nearly doubled to $12.2 million, but missed analyst estimates. GAAP net loss was $49.6 million. Management expects fiscal 2027 adjusted EBITDA of $68M-$75M. Cannabis sales represent 29% of total revenue.

yahoo.com3 min
AUG 21
$CURLFHighAI 8/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf (CURLF) has made an unsolicited bid for Aurora Cannabis (ACB), offering a 45% premium. Aurora's response was noncommittal. Canopy Growth (CGC) and Tilray Brands (TLRY) are also consolidating, with Tilray expanding into alcohol and CBD. Investors may benefit from acquisitions, but risks include integration challenges and leverage.

fool.com3 min